載入...
Administration costs of intravenous biologic drugs for rheumatoid arthritis
BACKGROUND: Cost-effectiveness studies explicitly reporting infusion times, drug-specific administration costs for infusions or real-payer intravenous drug cost are few in number. Yet, administration costs for infusions are needed in the health economic evaluations assessing intravenously-administer...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3825225/ https://ncbi.nlm.nih.gov/pubmed/24255834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-2-531 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|